Here we targeted the AT2R via the agonist, CGP42112A[14,15], in an orthotopic syngenic mouse model of CRC liver metastases in which we previously demonstrated inhibition of tumour growth following AT1R blockade [8]. This evidence concerns the gene AGTR1 and neoplasm.